NCT02143401 2024-11-22Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed29 enrolled
NCT04032392 2019-07-25Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT CellsBeijing 302 HospitalPhase 1 Unknown20 enrolled